Condition and perspective of renal replacement therapy (RRT) in children in the Republic of Belarus

Objective: to assess the incidence, prevalence and outcomes of end-stage renal disease (ESRD) in children in Belarus, age and gender of patients, etiology of renal diseases leading to ESRD. The study included 121 children, who received RRT as of January 01, 2007 and all subsequent new patients, who started this therapy before December 31, 2016. Results. The incidence of ESRD in  children in Belarus aged 0–14 years for the period 2007–2016 was 7 (6; 8) cases per year (4.8 (4.2; 5.2) per million age related population (pmarp)) and at the age of 0–17 years for the period 2009–2016 – 11 (9; 12) cases per year (5.6 (4.8; 6.8) pmarp). The prevalence of ESRD during the period from 2007 to 2016 increased by 31.7% in  the group of 0–14 years [from 26 patients (18.3 pmarp) to 38 (24.1 pmarp) patients], and by 46.7% aged 0–17 [from 37 (21 pmarp) to 57 (30.8 pmarp)]. The main cause of ESRD was congenital abnormality of kidneys and urinary tract (44.6% of cases). As of December 31, 2016, 75.4% of children were transplanted, 15.8% received peritoneal dialysis and 8.8% – hemodialysis. 5 year RRT mortality rate was 17.9 deaths per 1000 patient-years and main course of death was infection complications (50%). Conclusions. The incidence of ESRD in children in Belarus corresponds to the average of ESPN/ERA–EDTA Register, the prevalence islower, but with a constant growth. The low mortality rate of patients on RRT and high transplantation activity with insufficient number of preemptive transplantations is maintained.

1. Harambat J., van Stralen K.J., Kim J.J., Tizard E.J. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012; 27(3): 363–373. DOI: 10.1007/s00467-011-1939-1

2. Sukalo A.V., Bajko S.V. Dialysis and kidney transplantation in children in the Republic of Belarus. Nefrologija 2013; 17(3): 46–53. (in Russ)

3. Bajko S.V., Sukalo A.V. Protocol for the management of children after a related kidney transplantation. Nefrologija 2013; 17(3): 26–32. (in Russ)

4. Tizard E.J., Verrina E., van Stralen K.J., Jager K.J. Progress with the European society for paediatric nephrology (ESPN)/ ERA–EDTA registry for children with established renal failure (ERF). Nephrol Dial Transplant 2009; 24(9): 2615–2617. DOI: 10.1093/ndt/gfp275

5. Chesnaye N., Bonthuis M., Schaefer F., Groothoff J.W., Verrina E., Heaf J.G. et al. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA– EDTA registry. Pediatr Nephrol 2014; 29(12): 2403–2410. DOI: 10.1007/s00467-014-2884-6

6. ESPN/ERA–EDTA Registry: Annual reports. https:// www.espn-reg.org/index.jsp?p=pua Ссылка активна на 12.12.2017.

7. 2012 Primary Renal Disease (PRD) codes. https://www. era-edta-reg.org/files/annualreports/pdf/PRD_code_list.pdf Ссылка активна на 12.12.2017.

8. Schwartz G.J., Munoz A., Schneider M.F., Mak R.H., Kaskel F., Warady B.A. et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20(3): 629–637. DOI: 10.1681/ASN.2008030287

9. Paediatric renal replacement therapy / 20th report of the Malaysian dialysis and transplant registry 2012. https://www. msn.org.my/msn/Doc/PublicDoc_PB/Publication/nrr_report2012/chapter_5.pdf Ссылка активна на 14.12.2017.

10. Pediatric ESRD / 2012 U.S. Renal Data System annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. https://www.usrds.org/2012/ pdf/v2_ch8_12.pdf Ссылка активна на 29.12.2017.

11. Pediatric Report / ANZDATA Registry 2013. http://www. anzdata.org.au/anzdata/AnzdataReport/36thReport/201 3c11_paediatric_v1.8.pdf Ссылка активна на 29.12.2017.

12. ESRD Among Children, Adolescents, and Young Adults/2016 USRDS Annual data report https://www.usrds. org/2016/download/v2_c08_Pediatric_16.pdf Ссылка ак-тивна на 29.12.2017.

13. Bajko S.V., Sukalo A.V., Sudnovskaja K.A. Hemolytic-uremic syndrome in children: epidemiology, clinical and laboratory trends, treatment and outcomes (single-site study). Nefrologija i dializ 2016; 18(3): 282–299. (in Russ)

14. Chesnaye N.C., Schaefer F., Bonthuis M., Holman R., Baiko S., Baskin E. et al. Mortality Risk Disparities in Children Receiving Chronic Renal Replacement Therapy for the Treatment of End-Stage Renal Disease Across Europe: An ESPN/ ERA–EDTA Registry Analysis. Lancet 2017; 389(10084): 2128–2137. DOI: 10.1016/S0140-6736(17)30063-6